期刊文献+

无淋巴结转移胃癌患者的预后分析 被引量:4

Prognostic analysis on patients with lymph node-negative gastric cancer
原文传递
导出
摘要 目的 探讨无淋巴结转移胃癌患者的临床病理特征及预后影响因素.方法 回顾性分析天津医科大学总医院2004年1月至2013年12月间300例接受胃癌根治手术并且术后病理诊断为无淋巴结转移胃癌患者的临床病理资料,并对影响预后因素采用Kaplan-Meier法和Log-rank检验进行单因素分析,应用COX比例风险回归模型进行多因素分析.结果 本组300例无淋巴结转移胃癌患者术后1、3、5年总体生存率分别为80%、69%和63%.单因素分析结果显示肿瘤大小、组织学类型及浸润深度与患者预后相关(均P <0.05);多因素分析结果显示肿瘤大小(RR:1.800,95% CI:1.120 ~2.891,P=0.015)、组织学类型(RR:1.982,95% CI:1.291~3.042,P=0.002)和浸润深度(RR:1.464,95%CI:1.213 ~1.767,P=0.000)是影响本组胃癌患者预后的独立因素.结论 对于无淋巴结转移的胃癌患者,肿瘤大小、组织学类型和浸润深度是影响预后的重要因素. Objective To investigate the clinicopathological characteristics and prognosis in patients with node-negative gastric cancer.Methods Between January 2004 and December 2013,clinicopathological characteristics of 300 patients with node-negative gastric cancer who underwent radical gastrectomy in Tianjin Medical University General Hospital were retrospectively analyzed.Results The 1-,3-,and 5-year overall survival rates for patients with node-negative gastric cancer was 80%,69% and 63% respectively.The univariate analysis showed that tumor size,histologic type and depth of invasion had significant effects on the survival (P 〈 0.05).Multivariate analysis for these factors showed that tumor size (RR:1.800,95 % CI:1.120-2.891,P =0.015),histologic type (RR:1.982,95 % CI:1.291-3.042,P =0.002) and depth of invasion (RR:1.464,95% CI:1.213-1.767,P =0.000) were independent prognostic survival factors.Conclusions Tumor size,histologic type and depth of invasion are important prognostic factors of patients with node-negative gastric cancer.
出处 《中华普通外科杂志》 CSCD 北大核心 2015年第2期89-91,共3页 Chinese Journal of General Surgery
基金 天津市应用基础及前沿技术研究计划基金资助项目(09JCYBJC10200)
关键词 胃肿瘤 淋巴转移 预后 病理学 临床 Stomach neoplasms Lymphatic metastasis Prognosis Pathology,clinical
  • 相关文献

参考文献4

二级参考文献42

  • 1李玉明,詹文华,韩方海,何裕隆,彭俊生,蔡世荣,马晋平,赵刚.胃癌复发的类型、时间和危险因素分析[J].中华外科杂志,2006,44(3):174-176. 被引量:30
  • 2[1]Bozzetti F,Bonfanti G,Morabito A,Bufalino R,Menotti V,Andreola S,Doci R,Gennari L.A multifactorial approach for the prognosis of patients with carcinoma of the stomach after curative resection.Surg Gynecol Obstet 1986; 162:229-234
  • 3[2]Maruyama K.The most important prognostic factors for gastric cancer patients.Scand J Gastroenterol 1987; 22:63-68
  • 4[3]Adachi Y,Ogawa Y,Sasaki Y,Yukaya H,Mori M,Sugimachi K.A clinicopathologic study of gastric carcinoma with reference to age of patients.J Clin Gastroenterol 1994; 18:287-290
  • 5[4]Siewert JR,Bottcher K,Stein HJ,Roder JD.Relevant prognostic factors in gastric cancer:ten-year results of the German Gastric Cancer Study.Ann Surg 1998; 228:449-461
  • 6[5]Baba H,Maehara Y,Takeuchi H,Inutsuka S,Okuyama T,Adachi Y,Akazawa K,Sugimachi K.Effect of lymph node dissection on the prognosis in patients with node-negative early gastric cancer.Surgery 1995; 117:165-169
  • 7[6]Adachi Y,Mori M,Maehara Y,Kitano S,Sugimachi K.Prognostic factors of node-negative gastric carcinoma:univariate and multivariate analyses.JAm Coll Surg 1997; 184:373-377
  • 8[7]Maehara Y,Tomoda M,Tomisaki S,Ohmori M,Baba H,Akazawa K,Sugimachi K.Surgical treatment and outcome for node-negative gastric cancer.Surgery 1997; 121:633-639
  • 9[8]Bruno L,Nesi G,Montinaro F,Carassale G,Boddi V,Bechi P,Cortesini C.Clinicopathologic characteristics and outcome indicators in node-negative gastric cancer.J Surg Oncol 2000; 74:30-32
  • 10[9]Hyung WJ,Lee JH,Choi SH,Min JS,Noh SH.Prognostic impact of lymphatic and/or blood vessel invasion in patients with node-negative advanced gastric cancer.Ann Surg Oncol 2002; 9:562-567

共引文献150

同被引文献52

  • 1谢涛,林君荣.消化系统肿瘤患者的抗核抗体检测与临床意义[J].现代医药卫生,2007,23(7):1053-1053. 被引量:1
  • 2Lee J, Lim do H, Kim S, Park SH, Park JO, Park YS, Lim HY, Choi MG, Sohn TS, Noh JH, Bae JM, Ahn YC, Sohn I, Jung SH, Park CK, Kim KM, Kang WK. Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial. J Clin Oncol 2012; 30: 268-273.
  • 3Satoru M, Tomoo S, Masao H, Masayoshi S. A case of solitary splenic sarcoid reactions with advanced gastric cancer. Turk J Gastroenterol 2012; 23: 810-811.
  • 4Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010; 17: 1471-1474.
  • 5Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma - 2nd English Edition. Gastric Cancer 1998; 1: 10-24.
  • 6Hsu JT, Lin CJ, Sung CM, Yeh HC, Chen TH, Chen TC, Chiang KC, Yeh TS, Hwang TL, Jan YY. Prognostic significance of the number of examined lymph nodes in node-negative gastric adenocarcinoma. Eur J Surg Oncol 2013; 39: 1287-1293.
  • 7Jeong JY, Kim MG, Ha TK, Kwon SJ. Prognostic factors on overall survival in lymph node negative gastric cancer patients who underwent curative resection. J Gastric Cancer 2012; 12: 210-216.
  • 8Noguès C, Mouret-Fourme E. [Prophylactic surgery in common hereditary cancer syndromes]. Bull Acad Natl Med 2012; 196: 1237-1245.
  • 9Suzuki K, Noda Y, Fujita N, Hirasawa D, Obana T, Sugawara T, Ohira T, Harada Y, Maeda Y, Koike Y, Yamagata T, Kusaka J, Tanaka M, Sawai T, Kurose A. Clinicopathological study on endocrine cell micronests associated with early gastric cancer. Intern Med 2013; 52: 1311-1316.
  • 10Ishida M, Sekine S, Fukagawa T, Ohashi M, Morita S, Taniguchi H, Katai H, Tsuda H, Kushima R. Neuroendocrine carcinoma of the stomach: morphologic and immunohistochemical characteristics and prognosis. Am J Surg Pathol 2013; 37: 949-959.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部